Literature DB >> 11443139

Essential role of the conformational flexibility of helices 1 and 5 on the lipid binding activity of apolipophorin-III.

J L Soulages1, E L Arrese, P S Chetty, V Rodriguez.   

Abstract

It has been recently postulated that the conformational flexibility of helices 1 and 5 of Locusta migratoria apoLp-III could play an important role in early steps of binding of this apolipoprotein to a lipid surface (Soulages, J. L., and Arrese, E. L. (2000) J. Biol. Chem. 275, 17501-17509). To test this model, we have designed a double Cys mutant in which a disulfide bond linking helices 1 and 5 could be formed, resulting in an apolipoprotein with reduced conformational flexibility of its N- and C-terminal helices. Substitution of Thr(18) and Ala(147) by Cys residues provided a protein that under nonreducing conditions was fully oxidized. The far-UV CD spectra of this mutant in the reduced and oxidized states indicated that their secondary structures were identical to the structure of the wild type recombinant apoLp-III, which contains no Cys residues. Near-UV CD studies confirmed the formation of a disulfide bond and the absence of structural perturbations. The lipid binding activity of the reduced mutant, as determined by its ability to form discoidal lipoproteins, was nearly identical to that of the wild type protein. Contrarily, the disulfide form of the mutant was not able to form discoidal lipoproteins with liposomes of either dimirystoylphosphatidylcholine or dimyristoylphosphatidylglycerol. It is concluded that the separation of the helices 1 and 5 constitutes one of the key steps along the complex pathway for the formation of the final apolipoprotein lipid-bound state. It is inferred that the conformational flexibility of helices 1 and 5 is a key property of apoLp-III, allowing the exposure of hydrophobic protein regions and the interaction of the hydrophobic faces of the amphipathic alpha-helices with the lipoprotein lipid surface.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443139     DOI: 10.1074/jbc.M105836200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Apolipophorin III: lipopolysaccharide binding requires helix bundle opening.

Authors:  Leonardo J Leon; Hasitha Idangodage; Chung-Ping L Wan; Paul M M Weers
Journal:  Biochem Biophys Res Commun       Date:  2006-08-10       Impact factor: 3.575

2.  Helix 1 tryptophan variants in Galleria mellonella apolipophorin III.

Authors:  Jake Thistle; Daisy Martinon; Paul M M Weers
Journal:  Chem Phys Lipids       Date:  2015-10-14       Impact factor: 3.329

3.  Fragments of Locusta migratoria apoLp-III provide insight into lipid binding.

Authors:  Blair A Russell; James V C Horn; Paul M M Weers
Journal:  BBA Adv       Date:  2021-07-30

4.  Ecdysis triggering hormone peptide in the African malaria mosquito Anopheles gambiae: The peptide structure for receptor activation.

Authors:  Hawa Dembele; Moritz Mating; Rupinder Singh; Soheila Fatehi; Alvaro I Herrera; Yoonseong Park; Om Prakash
Journal:  Insect Sci       Date:  2022-02-09       Impact factor: 3.605

5.  Conformation of a group 2 late embryogenesis abundant protein from soybean. Evidence of poly (L-proline)-type II structure.

Authors:  Jose L Soulages; Kangmin Kim; Estela L Arrese; Christina Walters; John C Cushman
Journal:  Plant Physiol       Date:  2003-03       Impact factor: 8.340

6.  Transfer of C-terminal residues of human apolipoprotein A-I to insect apolipophorin III creates a two-domain chimeric protein with enhanced lipid binding activity.

Authors:  James V C Horn; Rachel A Ellena; Jesse J Tran; Wendy H J Beck; Vasanthy Narayanaswami; Paul M M Weers
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-04-21       Impact factor: 3.747

7.  Deletion of the N- or C-Terminal Helix of Apolipophorin III To Create a Four-Helix Bundle Protein.

Authors:  Pankaj Dwivedi; Johana Rodriguez; Nnejiuwa U Ibe; Paul M M Weers
Journal:  Biochemistry       Date:  2016-06-23       Impact factor: 3.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.